Cargando…
Concurrent administration of COVID-19 and influenza vaccines enhances Spike-specific antibody responses
The bivalent COVID-19 mRNA boosters became available in fall 2022 and were recommended alongside the seasonal influenza vaccine. However, the immunogenicity of concurrent versus separate administration of these vaccines remains unclear. Here, we analyzed antibody responses in healthcare workers who...
Autores principales: | Barouch, Susanna E., Chicz, Taras M., Blanc, Ross, Barbati, Domenic R., Parker, Lily J., Tong, Xin, McNamara, Ryan P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515870/ https://www.ncbi.nlm.nih.gov/pubmed/37745590 http://dx.doi.org/10.1101/2023.09.12.557347 |
Ejemplares similares
-
Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
por: Mackin, Samantha R., et al.
Publicado: (2022) -
Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccination
por: Tong, X., et al.
Publicado: (2023) -
Concurrent administration of COVID-19 vaccine and seasonal influenza vaccine: No increased estimated vaccine-related mortality rate
por: Sookaromdee, Pathum, et al.
Publicado: (2023) -
Efficacy of mRNA-1273 and Novavax ancestral or BA.1 spike booster vaccines against SARS-CoV-2 BA.5 infection in non-human primates
por: Routhu, Nanda Kishore, et al.
Publicado: (2023) -
Modeling and Manipulating Antibody Response Against Influenza and Coronavirus Spike Proteins and Exploring their Role in Directing Spike Evolution
por: Amitai, Assaf, et al.
Publicado: (2021)